Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 we wish to inform you that, the Trading window for dealing in the securities of the Company will remain closed w.e.f ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories has informed BSE that the trading window for dealing in its shares will be closed for all connected and designated persons (and their immediate relatives) starting October 1, 2025. The closure is in place pending the announcement of the unaudited financial results for the quarter and half-year ended September 30, 2025. The trading window will reopen 48 hours after these unaudited results are made publicly available. The intimation was signed by Whole-time Director Siddhartha Deorah.
This is a routine SEBI compliance filing. It restricts insider trading ahead of the Q2 FY26 results announcement but has no direct effect on retail shareholders or the stock price. Investors should watch for the upcoming quarterly results release.